This slide is based upon prokinetic agents with detailed descriptions of their dosage to be taken with their respective usage in conditions and effects to be careful. I hope you will get the best of your knowledge from the respective material.
This document discusses prokinetics, which are drugs that enhance gastrointestinal motility. It describes the normal control pathways of GI motility, including hormonal and neural pathways. It then discusses various phases of GI motility including the cephalic, gastric, and intestinal phases. The document outlines several prokinetic drug categories and examples, including muscarinic agonists, anticholinesterases, dopamine D2 blockers, 5-HT4 agonists, and motilin agonists. It discusses the mechanisms of action and advantages/disadvantages of various prokinetic drugs. Novel therapies for improving GI motility in critically ill patients are also mentioned.
Prokinetics are the type of drugs which enhances gastrointestinal motility/transit by
increasing the frequency or strength of contractions.
They speed up gastric emptying by enhancing coordinated propulsive motility.
Treat Gastrointestinal symptoms : Abdominal discomfort, Bloating, constipation,
Heart burn, nausea and vomiting. And few gastrointestinal disorders : irritable bowel
Syndrome, gastritis, gastroparesis and functional dyspepsia.
Increases gastric emptying
Relief of gastric stasis
Decreases reflux esophagitis/heart burn
Decreases regurgitation of gastric contents& emesis
The document discusses the physiology of vomiting and various emetics and antiemetics. It explains that vomiting is mediated by the vomiting center in the medulla oblongata which receives inputs from various areas. It then describes various emetics like apomorphine and ipecacuanha that directly stimulate the vomiting center. The rest of the document focuses on different classes of antiemetics like 5-HT3 antagonists, dopamine antagonists, antihistamines and their mechanisms and uses in conditions like motion sickness, postoperative nausea, chemotherapy-induced vomiting and morning sickness.
This document discusses antidiarrheal drugs and their mechanisms of action. It begins by defining diarrhea and describing the relevant pathophysiology of electrolyte and water absorption and secretion in the intestines. It then covers therapeutic measures for diarrhea including rehydration, nutrition, antimicrobial drugs for specific infections, probiotics, drugs for inflammatory bowel disease like 5-aminosalicylic acid compounds, corticosteroids, immunosuppressants, and TNF inhibitors. Finally, it discusses nonspecific antidiarrheal drugs that work by absorption, decreasing secretion, or decreasing motility, such as loperamide, diphenoxylate, and codeine.
This document provides an overview of different classes of antiemetic drugs, including their mechanisms of action, pharmacokinetics, and clinical uses. It discusses 5HT3 antagonists like ondansetron, prokinetic drugs like metoclopramide, neuroleptics, H1 antihistamines, anticholinergics, and corticosteroids like dexamethasone. The document also reviews the pathophysiology of nausea and vomiting, focusing on the role of the chemoreceptor trigger zone and receptors like 5HT3, dopamine D2, muscarinic, and histaminic H1. It provides dosing guidelines for representative drugs in each class.
Antiemetics and prokinetics classification with mechansim SONALPANDE5
This document provides information on antiemetics and prokinetics. It discusses nausea, emesis, and the various receptor types involved in vomiting including acetylcholine, dopamine, histamine, serotonin, substance P, and opioid receptors. It covers the etiology, pathophysiology, and classification of conditions causing nausea and vomiting. Various receptor antagonist antiemetics are described including H1 receptor antagonists like cyclizine, muscarinic receptor antagonists like hyoscine, 5-HT3 receptor antagonists like ondansetron, dopamine antagonists like chlorpromazine, and NK1 receptor antagonists like aprepitant. Adjuvant antiemetics including dexamethasone and
This document discusses various drug classes used to treat type 2 diabetes, including their mechanisms of action, pharmacokinetics, and side effects. It describes sulfonylureas, metformin, thiazolidinediones, meglitinide analogues, DPP-4 inhibitors, GLP-1 receptor agonists, alpha-glucosidase inhibitors, amylin analogues, and SGLT2 inhibitors. For each class, it provides details on representative drugs, how they work, considerations around use, and common adverse effects. The document aims to comprehensively cover oral and injectable pharmacologic options for managing hyperglycemia in type 2 diabetes.
This document discusses prokinetics, which are drugs that enhance gastrointestinal motility. It describes the normal control pathways of GI motility, including hormonal and neural pathways. It then discusses various phases of GI motility including the cephalic, gastric, and intestinal phases. The document outlines several prokinetic drug categories and examples, including muscarinic agonists, anticholinesterases, dopamine D2 blockers, 5-HT4 agonists, and motilin agonists. It discusses the mechanisms of action and advantages/disadvantages of various prokinetic drugs. Novel therapies for improving GI motility in critically ill patients are also mentioned.
Prokinetics are the type of drugs which enhances gastrointestinal motility/transit by
increasing the frequency or strength of contractions.
They speed up gastric emptying by enhancing coordinated propulsive motility.
Treat Gastrointestinal symptoms : Abdominal discomfort, Bloating, constipation,
Heart burn, nausea and vomiting. And few gastrointestinal disorders : irritable bowel
Syndrome, gastritis, gastroparesis and functional dyspepsia.
Increases gastric emptying
Relief of gastric stasis
Decreases reflux esophagitis/heart burn
Decreases regurgitation of gastric contents& emesis
The document discusses the physiology of vomiting and various emetics and antiemetics. It explains that vomiting is mediated by the vomiting center in the medulla oblongata which receives inputs from various areas. It then describes various emetics like apomorphine and ipecacuanha that directly stimulate the vomiting center. The rest of the document focuses on different classes of antiemetics like 5-HT3 antagonists, dopamine antagonists, antihistamines and their mechanisms and uses in conditions like motion sickness, postoperative nausea, chemotherapy-induced vomiting and morning sickness.
This document discusses antidiarrheal drugs and their mechanisms of action. It begins by defining diarrhea and describing the relevant pathophysiology of electrolyte and water absorption and secretion in the intestines. It then covers therapeutic measures for diarrhea including rehydration, nutrition, antimicrobial drugs for specific infections, probiotics, drugs for inflammatory bowel disease like 5-aminosalicylic acid compounds, corticosteroids, immunosuppressants, and TNF inhibitors. Finally, it discusses nonspecific antidiarrheal drugs that work by absorption, decreasing secretion, or decreasing motility, such as loperamide, diphenoxylate, and codeine.
This document provides an overview of different classes of antiemetic drugs, including their mechanisms of action, pharmacokinetics, and clinical uses. It discusses 5HT3 antagonists like ondansetron, prokinetic drugs like metoclopramide, neuroleptics, H1 antihistamines, anticholinergics, and corticosteroids like dexamethasone. The document also reviews the pathophysiology of nausea and vomiting, focusing on the role of the chemoreceptor trigger zone and receptors like 5HT3, dopamine D2, muscarinic, and histaminic H1. It provides dosing guidelines for representative drugs in each class.
Antiemetics and prokinetics classification with mechansim SONALPANDE5
This document provides information on antiemetics and prokinetics. It discusses nausea, emesis, and the various receptor types involved in vomiting including acetylcholine, dopamine, histamine, serotonin, substance P, and opioid receptors. It covers the etiology, pathophysiology, and classification of conditions causing nausea and vomiting. Various receptor antagonist antiemetics are described including H1 receptor antagonists like cyclizine, muscarinic receptor antagonists like hyoscine, 5-HT3 receptor antagonists like ondansetron, dopamine antagonists like chlorpromazine, and NK1 receptor antagonists like aprepitant. Adjuvant antiemetics including dexamethasone and
This document discusses various drug classes used to treat type 2 diabetes, including their mechanisms of action, pharmacokinetics, and side effects. It describes sulfonylureas, metformin, thiazolidinediones, meglitinide analogues, DPP-4 inhibitors, GLP-1 receptor agonists, alpha-glucosidase inhibitors, amylin analogues, and SGLT2 inhibitors. For each class, it provides details on representative drugs, how they work, considerations around use, and common adverse effects. The document aims to comprehensively cover oral and injectable pharmacologic options for managing hyperglycemia in type 2 diabetes.
Antiemetics are drugs that prevent nausea and vomiting. They work by blocking receptors in the vomiting center of the brain such as H1 receptors, muscarinic receptors, dopamine D2 receptors, and 5-HT3 receptors. Common antiemetics include antihistamines like cyclizine for motion sickness, scopolamine for motion sickness, phenothiazines like prochlorperazine for chemotherapy induced vomiting, and 5-HT3 receptor antagonists like ondansetron for chemotherapy and radiation induced vomiting. The document discusses the mechanisms and uses of various classes of antiemetic drugs for conditions like morning sickness, motion sickness, vertigo, and vomiting caused by chemotherapy, radiation, or other illnesses.
This document discusses drugs used to treat constipation and diarrhea. For constipation, it describes laxatives that promote bowel evacuation, including bulk formers, stool softeners, and stimulant purgatives. For diarrhea, it outlines rehydration therapy and maintaining nutrition. Drug treatment includes specific antimicrobials, probiotics, drugs for inflammatory bowel disease, and nonspecific antidiarrheal drugs that are absorbents, antisecretory, or antimotility agents.
1) The document discusses drugs used in the treatment of constipation, including laxatives, which are classified based on their mechanism and intensity of action.
2) Bulk forming agents like fiber, psyllium, and methylcellulose work by absorbing water in the intestines and forming a gel, which softens stool and increases stool mass. Stool softeners like docusates and liquid paraffin work by a detergent action that softens stool.
3) Stimulant purgatives like bisacodyl and senna irritate the intestinal mucosa, increasing motility and fluid accumulation in the intestines. They have more potent effects than bulk formers or softeners.
This document discusses the pharmacology of the gastrointestinal tract. It begins by outlining conditions where gastrointestinal intervention may be necessary, such as motility disorders, absorption disorders, and peptic lesions. It then focuses on the regulation of nausea and vomiting, including the vomiting center in the brain and various mediators like dopamine, serotonin, and histamine. It describes different classes of antiemetics that act on these mediators, including serotonin 5-HT3 receptor antagonists, histamine H1 receptor antagonists, and dopamine D2 receptor antagonists. Finally, it discusses prokinetics, treatments for peptic ulcer like proton pump inhibitors, and Helicobacter pylori infection.
Antithyroid drugs work by inhibiting thyroid hormone synthesis or release. The major drugs used are carbimazole and propylthiouracil, which inhibit hormone synthesis. Carbimazole is more potent and given once daily, while propylthiouracil is dosed three times daily. Iodide salts rapidly inhibit hormone release and synthesis. Radioactive iodine is concentrated in the thyroid where it destroys follicular cells. Beta-blockers alleviate symptoms of overactivity and reduce peripheral hormone conversion. These drugs control hyperthyroidism from Graves' disease and toxic nodular goiter.
This document summarizes different types of oral hypoglycemic agents (drugs used to lower blood glucose levels orally). It discusses sulfonylureas, biguanides, meglitinides, thiazolidinediones, and alpha-glucosidase inhibitors. For each class, it describes the mechanism of action, pharmacokinetics, adverse drug reactions, and examples of drugs from each class like glibenclamide, metformin, repaglinide, rosiglitazone, and acarbose. It also briefly mentions newer anti-diabetic drugs like SGLT-2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists that have been approved
Diarrhea is a major cause of morbidity and mortality in developing countries. The mainstay of treatment is to correct fluid and electrolyte imbalance through oral rehydration therapy or IV fluids. Specific treatment depends on the cause and includes antimicrobial agents for infectious diarrhea and anti-motility drugs for non-infectious diarrhea. Anti-motility drugs like loperamide work by increasing intestinal transit time through mu and delta opioid receptors while anticholinergics decrease bowel motility and secretion. Antimicrobials are useful for specific infections while anti-inflammatory drugs are used for conditions like ulcerative colitis.
Hypolipidaemics pharmacology with a note on Statins /Fibrates/ Sterol absorption Inhibitors/ CETP Inhibitors / Lipoprotein Lipase activators and Bile acid sequestrants
This document discusses oral hypoglycemic drugs and insulin used to treat diabetes. It describes the two main types of diabetes - type 1 caused by insulin deficiency and type 2 caused by insulin resistance. The document outlines several classes of oral hypoglycemic drugs including biguanides, sulfonylureas, meglitinides, thiazolidinediones, and alpha-glucosidase inhibitors. It provides details on the mechanism of action, pharmacokinetics, effects and side effects of drugs from each class.
This document discusses macrolide antibiotics. It begins by introducing macrolides as a class of antibiotics characterized by a macrocyclic lactone ring to which sugars are attached. It then focuses on individual macrolides including erythromycin, clarithromycin, azithromycin, roxithromycin, and spiramycin. The document discusses the mechanism of action, spectrum of activity, resistance, pharmacokinetics, uses, interactions, and adverse effects of macrolide antibiotics.
introduction ,classification of cholinergic receptor ,and its function ,anti cholinergic agents -atropine and its pharmacology ,semi synthetic and synthetic atropine substitutes
This document discusses the causes, treatment, and management of diarrhea. It begins by defining diarrhea as three or more loose stools in a 24 hour period. The causes of diarrhea include osmotic, secretory, motility issues, altered morphology, allergies, drugs, and certain cancers. Treatment involves rehydration either orally or intravenously. Oral rehydration solutions contain sodium, potassium, citrate, and glucose. Antimicrobial therapy may be used for certain infectious causes. Probiotics can help with antibiotic-associated diarrhea. Management of inflammatory bowel disease is also discussed.
This document discusses drugs that affect the gastrointestinal system. It covers topics including peptic ulcer disease, constipation, diarrhea, vomiting, and digestion. It describes factors that increase or decrease acidity in peptic ulcer disease. It then summarizes different drug classes used to treat peptic ulcers, constipation, diarrhea, vomiting, and digestive issues. These include H2 receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandin analogs, antacids, antibiotics, laxatives, antidiarrheals, antiemetics, and digestion aids.
This document provides information on the pharmacology of diuretics. It begins by explaining that diuretics cause a net loss of sodium and water in urine but sodium balance is restored through homeostatic mechanisms. It then classifies diuretics and describes various classes in detail, including their mechanisms and sites of action, uses, and adverse effects. The classes discussed include high efficacy loop diuretics like furosemide, medium efficacy thiazides, weak carbonic anhydrase inhibitors, potassium sparing aldosterone antagonists, and renal sodium channel inhibitors.
Lecture covers the pharmacology of anticholinergic drugs. Includes classification, therapeutic uses, adverse effects of anticholinergics. Atropine has been described as prototype drug.
Presentation for Medical undergraduates for teaching pharmacology. It deals with Physiology of steroid hormones and their action along with agents which are used therapeutically with their action, adverse effects and therapeutic uses.
The document discusses drugs used to treat peptic ulcers, gastroesophageal reflux disease, diarrhea, and constipation. It describes the causes of peptic ulcers including H. pylori infection and NSAID use. Treatment involves eradicating H. pylori, reducing gastric acid with H2 blockers or proton pump inhibitors, and protecting the gastric mucosa. Various classes of drugs are covered that act on these mechanisms including antimicrobials, H2 blockers, proton pump inhibitors, prostaglandins, and antacids.
This document discusses the pharmacotherapy of peptic ulcers. It begins by classifying the main drugs used: 1) those that inhibit gastric acid secretion like H2 blockers and proton pump inhibitors, 2) antacids that neutralize acid, 3) ulcer protectives like sucralfate, and 4) anti-H. pylori drugs for eradication. It then goes into detail about the mechanisms, uses, and side effects of the major drug classes. H2 blockers competitively block H2 receptors to suppress acid secretion. Proton pump inhibitors irreversibly inactivate the H+/K+ ATPase pump for prolonged acid inhibition. Antacids chemically neutralize acid. Sucralfate
The document discusses various causes, pathophysiology, and treatment of emesis and nausea. It covers the following topics:
- Emetics that induce vomiting and their mechanisms of action.
- Various classes of anti-emetics including antihistamines, neuroleptics, 5-HT3 antagonists, NK1 antagonists, cannabinoids, glucocorticoids, benzodiazepines and their mechanisms and uses.
- Prokinetic drugs like metoclopramide and domperidone that enhance gastrointestinal motility.
- Specific conditions like motion sickness, nausea during pregnancy, chemotherapy-induced nausea and vomiting, post-operative nausea and specific
This slide consists of details related to Peptic ulcers and what can be the possible drugs to be used with their overview. I hope this will be helpful for all readers.
Antiemetics are drugs that prevent nausea and vomiting. They work by blocking receptors in the vomiting center of the brain such as H1 receptors, muscarinic receptors, dopamine D2 receptors, and 5-HT3 receptors. Common antiemetics include antihistamines like cyclizine for motion sickness, scopolamine for motion sickness, phenothiazines like prochlorperazine for chemotherapy induced vomiting, and 5-HT3 receptor antagonists like ondansetron for chemotherapy and radiation induced vomiting. The document discusses the mechanisms and uses of various classes of antiemetic drugs for conditions like morning sickness, motion sickness, vertigo, and vomiting caused by chemotherapy, radiation, or other illnesses.
This document discusses drugs used to treat constipation and diarrhea. For constipation, it describes laxatives that promote bowel evacuation, including bulk formers, stool softeners, and stimulant purgatives. For diarrhea, it outlines rehydration therapy and maintaining nutrition. Drug treatment includes specific antimicrobials, probiotics, drugs for inflammatory bowel disease, and nonspecific antidiarrheal drugs that are absorbents, antisecretory, or antimotility agents.
1) The document discusses drugs used in the treatment of constipation, including laxatives, which are classified based on their mechanism and intensity of action.
2) Bulk forming agents like fiber, psyllium, and methylcellulose work by absorbing water in the intestines and forming a gel, which softens stool and increases stool mass. Stool softeners like docusates and liquid paraffin work by a detergent action that softens stool.
3) Stimulant purgatives like bisacodyl and senna irritate the intestinal mucosa, increasing motility and fluid accumulation in the intestines. They have more potent effects than bulk formers or softeners.
This document discusses the pharmacology of the gastrointestinal tract. It begins by outlining conditions where gastrointestinal intervention may be necessary, such as motility disorders, absorption disorders, and peptic lesions. It then focuses on the regulation of nausea and vomiting, including the vomiting center in the brain and various mediators like dopamine, serotonin, and histamine. It describes different classes of antiemetics that act on these mediators, including serotonin 5-HT3 receptor antagonists, histamine H1 receptor antagonists, and dopamine D2 receptor antagonists. Finally, it discusses prokinetics, treatments for peptic ulcer like proton pump inhibitors, and Helicobacter pylori infection.
Antithyroid drugs work by inhibiting thyroid hormone synthesis or release. The major drugs used are carbimazole and propylthiouracil, which inhibit hormone synthesis. Carbimazole is more potent and given once daily, while propylthiouracil is dosed three times daily. Iodide salts rapidly inhibit hormone release and synthesis. Radioactive iodine is concentrated in the thyroid where it destroys follicular cells. Beta-blockers alleviate symptoms of overactivity and reduce peripheral hormone conversion. These drugs control hyperthyroidism from Graves' disease and toxic nodular goiter.
This document summarizes different types of oral hypoglycemic agents (drugs used to lower blood glucose levels orally). It discusses sulfonylureas, biguanides, meglitinides, thiazolidinediones, and alpha-glucosidase inhibitors. For each class, it describes the mechanism of action, pharmacokinetics, adverse drug reactions, and examples of drugs from each class like glibenclamide, metformin, repaglinide, rosiglitazone, and acarbose. It also briefly mentions newer anti-diabetic drugs like SGLT-2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists that have been approved
Diarrhea is a major cause of morbidity and mortality in developing countries. The mainstay of treatment is to correct fluid and electrolyte imbalance through oral rehydration therapy or IV fluids. Specific treatment depends on the cause and includes antimicrobial agents for infectious diarrhea and anti-motility drugs for non-infectious diarrhea. Anti-motility drugs like loperamide work by increasing intestinal transit time through mu and delta opioid receptors while anticholinergics decrease bowel motility and secretion. Antimicrobials are useful for specific infections while anti-inflammatory drugs are used for conditions like ulcerative colitis.
Hypolipidaemics pharmacology with a note on Statins /Fibrates/ Sterol absorption Inhibitors/ CETP Inhibitors / Lipoprotein Lipase activators and Bile acid sequestrants
This document discusses oral hypoglycemic drugs and insulin used to treat diabetes. It describes the two main types of diabetes - type 1 caused by insulin deficiency and type 2 caused by insulin resistance. The document outlines several classes of oral hypoglycemic drugs including biguanides, sulfonylureas, meglitinides, thiazolidinediones, and alpha-glucosidase inhibitors. It provides details on the mechanism of action, pharmacokinetics, effects and side effects of drugs from each class.
This document discusses macrolide antibiotics. It begins by introducing macrolides as a class of antibiotics characterized by a macrocyclic lactone ring to which sugars are attached. It then focuses on individual macrolides including erythromycin, clarithromycin, azithromycin, roxithromycin, and spiramycin. The document discusses the mechanism of action, spectrum of activity, resistance, pharmacokinetics, uses, interactions, and adverse effects of macrolide antibiotics.
introduction ,classification of cholinergic receptor ,and its function ,anti cholinergic agents -atropine and its pharmacology ,semi synthetic and synthetic atropine substitutes
This document discusses the causes, treatment, and management of diarrhea. It begins by defining diarrhea as three or more loose stools in a 24 hour period. The causes of diarrhea include osmotic, secretory, motility issues, altered morphology, allergies, drugs, and certain cancers. Treatment involves rehydration either orally or intravenously. Oral rehydration solutions contain sodium, potassium, citrate, and glucose. Antimicrobial therapy may be used for certain infectious causes. Probiotics can help with antibiotic-associated diarrhea. Management of inflammatory bowel disease is also discussed.
This document discusses drugs that affect the gastrointestinal system. It covers topics including peptic ulcer disease, constipation, diarrhea, vomiting, and digestion. It describes factors that increase or decrease acidity in peptic ulcer disease. It then summarizes different drug classes used to treat peptic ulcers, constipation, diarrhea, vomiting, and digestive issues. These include H2 receptor antagonists, proton pump inhibitors, anticholinergics, prostaglandin analogs, antacids, antibiotics, laxatives, antidiarrheals, antiemetics, and digestion aids.
This document provides information on the pharmacology of diuretics. It begins by explaining that diuretics cause a net loss of sodium and water in urine but sodium balance is restored through homeostatic mechanisms. It then classifies diuretics and describes various classes in detail, including their mechanisms and sites of action, uses, and adverse effects. The classes discussed include high efficacy loop diuretics like furosemide, medium efficacy thiazides, weak carbonic anhydrase inhibitors, potassium sparing aldosterone antagonists, and renal sodium channel inhibitors.
Lecture covers the pharmacology of anticholinergic drugs. Includes classification, therapeutic uses, adverse effects of anticholinergics. Atropine has been described as prototype drug.
Presentation for Medical undergraduates for teaching pharmacology. It deals with Physiology of steroid hormones and their action along with agents which are used therapeutically with their action, adverse effects and therapeutic uses.
The document discusses drugs used to treat peptic ulcers, gastroesophageal reflux disease, diarrhea, and constipation. It describes the causes of peptic ulcers including H. pylori infection and NSAID use. Treatment involves eradicating H. pylori, reducing gastric acid with H2 blockers or proton pump inhibitors, and protecting the gastric mucosa. Various classes of drugs are covered that act on these mechanisms including antimicrobials, H2 blockers, proton pump inhibitors, prostaglandins, and antacids.
This document discusses the pharmacotherapy of peptic ulcers. It begins by classifying the main drugs used: 1) those that inhibit gastric acid secretion like H2 blockers and proton pump inhibitors, 2) antacids that neutralize acid, 3) ulcer protectives like sucralfate, and 4) anti-H. pylori drugs for eradication. It then goes into detail about the mechanisms, uses, and side effects of the major drug classes. H2 blockers competitively block H2 receptors to suppress acid secretion. Proton pump inhibitors irreversibly inactivate the H+/K+ ATPase pump for prolonged acid inhibition. Antacids chemically neutralize acid. Sucralfate
The document discusses various causes, pathophysiology, and treatment of emesis and nausea. It covers the following topics:
- Emetics that induce vomiting and their mechanisms of action.
- Various classes of anti-emetics including antihistamines, neuroleptics, 5-HT3 antagonists, NK1 antagonists, cannabinoids, glucocorticoids, benzodiazepines and their mechanisms and uses.
- Prokinetic drugs like metoclopramide and domperidone that enhance gastrointestinal motility.
- Specific conditions like motion sickness, nausea during pregnancy, chemotherapy-induced nausea and vomiting, post-operative nausea and specific
This slide consists of details related to Peptic ulcers and what can be the possible drugs to be used with their overview. I hope this will be helpful for all readers.
Emetics, antiemetics and prokinetic agents.pptxsapnabohra2
The document discusses emetics and antiemetics. It describes the physiology of vomiting and pathophysiology of cytotoxic drug-induced vomiting. It discusses various emetics like apomorphine, ipecacuanha, and their mechanisms of action. It also discusses various classes of antiemetics like dopamine D2 antagonists, 5-HT3 antagonists, antimuscarinics, neuroleptics, neurokinin receptor antagonists and others. It provides details about specific drugs from these classes like ondansetron, metoclopramide, domperidone. It also discusses prokinetic agents that enhance gastrointestinal motility like metoclopramide, domperidone,
This document provides notes on drugs used in the management of gastrointestinal disorders, focusing on antiemetic, prokinetic, and digestant agents. It discusses the physiology of vomiting and conditions that can cause it. It then summarizes various classes of antiemetic drugs including anticholinergics, H1 antihistamines, neuroleptics, prokinetic drugs, 5-HT3 antagonists, NK1 receptor antagonists, and adjuvant antiemetics. One key prokinetic drug, metoclopramide, is discussed in depth regarding its mechanisms and uses in gastrointestinal disorders. Another prokinetic, domperidone, is also briefly mentioned.
Introduction TO VOMITING,Pathophysiology of vomiting,Emetics,Anti emetics,classification,pharmacology,Drug treatment in selected circumstances FOR EMETICS were included.
This document discusses anti-emetics, or drugs used to treat nausea and vomiting. It begins by explaining that nausea and vomiting are protective reflexes, and describes the mechanisms of vomiting control in the brain and peripheral areas. It then categorizes and describes different classes of anti-emetics including anticholinergics, antihistamines, neuroleptics, prokinetic drugs, 5-HT3 antagonists, and others. Specific anti-emetic drugs like metoclopramide, domperidone, and cisapride are also outlined with their mechanisms of action and uses.
This document discusses drugs acting on the gastrointestinal tract, including those used to treat peptic ulcer disease, antiemetics, and laxatives. It outlines various drug classes used for peptic ulcers like H2 receptor antagonists, proton pump inhibitors, and antibiotics for H. pylori. It also describes antiemetic drugs that work on different receptor types to treat nausea and vomiting. Finally, it covers different classes of laxatives like bulk forming, stool softeners, lubricants, osmotic, and stimulant laxatives.
This document provides an overview of drugs acting on the gastrointestinal tract. It discusses the major parts of the GIT and disorders related to it like peptic ulcer and achlorhydria. It then covers the different classes of drugs used to treat GIT disorders like antiulcer drugs, drugs for achlorhydria, antiemetics, antidiarrheal agents, and laxatives. The mechanisms and examples of commonly used drugs from each class are described in detail.
This document discusses drugs that induce vomiting (emetics) or prevent vomiting (antiemetics). It describes the mechanisms of vomiting and classifies various emetics such as apomorphine, mustard, and ipecacuanha. It also categorizes and explains examples of different types of antiemetics, including prokinetics like metoclopramide, antimuscarinics like hyoscine, antihistamines, neuroleptics, and 5-HT3 antagonists like ondansetron and granisetron. The document provides details on the mechanisms, dosages, and side effects of these selected emetic and antiemetic drugs.
This document provides information on drugs acting on the gastrointestinal tract. It discusses disorders of the GIT like peptic ulcer, achlorhydria, emesis, diarrhea, and constipation. It then describes the major classes of drugs used to treat these conditions, including antiulcer drugs, drugs for achlorhydria, antiemetics, antidiarrheal agents, and laxatives. The mechanisms and examples of specific drugs from different classes are outlined, such as H2 receptor blockers, proton pump inhibitors, and anticholinergics for ulcers.
This document discusses different types of emetics and antiemetics. It begins by describing the mechanism of vomiting and pathways involved. It then categorizes emetics based on their site of action - centrally acting (apomorphine, morphine), peripherally acting (mustard, tartar emetic), or both (ipecacuanha). Various centrally, peripherally and dual acting emetics are then described in more detail. The document concludes by covering different classes of antiemetics including anticholinergics, antihistamines, neuroleptics, prokinetic drugs, 5-HT3 antagonists, and adjuvant antiemetics.
Emetics & Anti-emetics presentation for pharmacy studentsLokesh Patil
Emetics and antiemetics are drugs used to induce and prevent vomiting, respectively. Emetics, such as ipecac syrup and apomorphine, stimulate the vomiting center in the brain or irritate the stomach lining to induce vomiting, often used in cases of poisoning. Antiemetics, including drugs like ondansetron, metoclopramide, and promethazine, work by blocking neurotransmitters like serotonin, dopamine, and histamine, which are involved in triggering the vomiting reflex. They are commonly used to treat nausea and vomiting caused by conditions such as motion sickness, chemotherapy, and postoperative recovery. Understanding the mechanisms and applications of these drugs is crucial for effectively managing emesis in various clinical scenarios.
This document discusses antiemetics and prokinetics. It begins by describing the physiology of vomiting and stimuli pathways and centers that mediate the emetic reflex. It then covers various classes of antiemetics including dopamine D2 antagonists, 5-HT3 antagonists, antimuscarinics, neuroleptics, and other agents. Prokinetics are also discussed, focusing on their mechanisms of action to enhance gastrointestinal motility. Common prokinetic drugs like metoclopramide, cisapride, and erythromycin are described along with their uses and adverse effects.
This document discusses the treatment of peptic ulcers, including antacids, H2 receptor antagonists, proton pump inhibitors, mucosal protective agents, and eradication of H. pylori. It provides details on the mechanisms of action, dosages, side effects and drug interactions of the various classes of drugs used to treat peptic ulcers. It also mentions that certain drugs like NSAIDs and glucocorticoids can cause peptic ulcers.
Emetics and antiemetics are used to induce or prevent vomiting. Emetics work centrally in the medulla, peripherally in the stomach, or both. Common emetics include apomorphine, mustard, and ipecacuanha. Antiemetics have various mechanisms of action and include anticholinergics, antihistamines, neuroleptics, prokinetic drugs, 5-HT3 antagonists, and adjuvant medications. Common antiemetics are hyoscine, promethazine, metoclopramide, ondansetron, and corticosteroids. These drugs are used to treat nausea and vomiting from different causes like motion sickness, chemotherapy,
Antimuscarinic Agents 2 Power Point Presentationhareesh c
This document compares and contrasts the properties and clinical uses of various anticholinergic and antimuscarinic drugs. It discusses how atropine and hyoscine differ in their effects on various organ systems. It also outlines the properties and indications of various quaternary ammonium compounds, tertiary amines, and mydriatic drugs used in ophthalmology.
Emetics & Anti-emetics are used to induce or treat nausea and vomiting. There are various classifications and mechanisms of action. Emetics like apomorphine and ipecacuanha act on the chemoreceptor trigger zone to induce vomiting. Anti-emetics from different classes like antihistamines, antimuscarinics, dopamine antagonists, 5-HT3 receptor antagonists, cannabinoids, benzodiazepines and glucocorticoids are used to treat nausea and vomiting through various receptor mechanisms with some adverse effects. Combination therapy provides better efficacy with lower adverse effects.
This document discusses various classes of drugs used as antiemetics and their mechanisms of action. It addresses the following key points:
1. Serotonin 5-HT3 antagonists like ondansetron, granisetron, and dolasetron are very effective antiemetics for chemotherapy-induced nausea and vomiting. However, ondansetron would not be effective for motion sickness because the vestibular nuclei responsible for motion sickness only have muscarinic and H1 histaminic receptors.
2. Dopamine D2 antagonists like metoclopramide and domperidone are also used as antiemetics and prokinetics due to their effects on the chemore
Pharmacology for Physiotherapy Book By Padmaja Udaykumar Second Edition.Khalid Ghaznavi
Pharmacology for Physiotherapy Book
By Padmaja Udaykumar Second Edition.
This consists of a complete book version. I hope this will be helpful for you.
Falls and Preventive Measure of Fall in ElderlyKhalid Ghaznavi
The document discusses balance and falls in elderly patients. It notes that falls are a major cause of mortality, morbidity, fractures, and loss of independence in elderly individuals. The causes of falls are often multi-factorial, involving both intrinsic patient factors like aging, poor balance, and chronic conditions as well as extrinsic environmental hazards. A thorough evaluation of elderly fall risk involves assessing the patient's medical history, performing physical exams of systems like vision and sensation that affect balance, and testing the patient's balance, gait, and fall response strategies.
This document discusses different types of ankle foot orthoses (AFOs). AFOs are used to control ankle motion and provide stability. There are conventional metal AFOs, molded plastic AFOs, posterior leaf spring AFOs, solid ankle AFOs, spiral AFOs, hinged AFOs, and patellar tendon weight bearing orthoses. The document provides details on the characteristics and purposes of each type of AFO.
The document discusses evaluation (checkout) procedures for lower limb orthoses. Checkout involves initial, final, static, and dynamic evaluations. Initial checkout is done before training to ensure proper fitting and make adjustments, while final checkout occurs after training to assess effectiveness. Static evaluation observes fit and alignment in sitting and standing. Dynamic evaluation assesses gait. The goal of checkout is to ensure proper fit, comfort, stability, and patient satisfaction with the orthosis.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
2. Pro-Kinetic Agents
Drugs that….
enhance gastro-duodenal motility and
hasten the gastric motility
Metoclopramide
Domperidone
Cisapride
Mosapride Dr.Khalid Ghaznavi
(DPT)
3. --METOCLOPRAMIDE--
Actions GIT:
Promotes forward movement of upper GIT
Speeds up gastric emptying
Prevents reflex esophagitis
Slightly increase intestinal motility/peristalasis.
CNS Actions:
Acts as anti-emetic by
actions on CTZ and
by speeding up the gastric emptying
Dr.Khalid Ghaznavi
(DPT)
4. Mechanism of action of Metoclopramide
By Blocking dopamine receptors in the gut
By Enhancing acetylcholine release from the cholinergic neurons in the
gut
By Blocking the D2 receptors in the CTZ-responsible for anti-emetic
action
Dr.Khalid Ghaznavi
(DPT)
5. Adverse effects of Metoclopramide
Sedation
Dystonia
Diarrhea
Gynecomastia
Galactorrhea
Parkinsonism (extra-pyramidal symptoms) can occur on long term
use due to blockade of dopamine receptors.
Dr.Khalid Ghaznavi
(DPT)
6. Uses of Metoclopramide
Reflux esophagitis
Heart burn due to reflex of acid into esophagus is benefited by prokinetic
agents.
As anti-emetic
In post-operative period and vomiting due to anti-cancer drugs.
As pre-anesthetic medication
To promote gastric emptying before induction of general anesthesia in
emergency.
In Endoscopy
to assist the passage of tubes into duodenum
Dr.Khalid Ghaznavi
(DPT)
7. --DOMPERIDONE--
Similar to metoclopramide;
Except it does not cross Blood Brain Barrier
Hence does not cause extra-pyramidal side effects
Side effects include;
✓ Headache
✓ Dryness of mouth
✓ Diarrhea
✓ Rashes
Domperidone can be used in place of metoclopramide.
Dr.Khalid Ghaznavi
(DPT)
8. --CISAPRIDE--
Enhance gastric motility by promoting the release of
acetylcholine in gut wall
Promotes colonic motility which may result in diarrhea
Used in reflux esophagitis
But not being used because of their adverse effects now a days
Dr.Khalid Ghaznavi
(DPT)
10. Emetics
“A protective reflex that
serves to rid the stomach and intestine of toxic substances and
prevent their further ingestion.”
Occurs due to stimulation of the
emetic/vomiting center situated in the medulla oblongata
Dr.Khalid Ghaznavi
(DPT)
11. Multiple pathways can
elicit vomiting
Vomiting center receives
afferents impulses arising from
◼ CTZ ,
◼ GI Tract,
◼ throat ,
◼ vestibular apparatus and
◼ other viscera
CTZ is also accessible;
blood borne drugs,
mediators,
hormones,
toxins etc.
Dr.Khalid Ghaznavi
(DPT)
12. Emetics –centrally acting Apomorphine
Derivative of morphine.
Given S.C/I.M -6mg
Causes vomiting within 5-10 min
Vomiting is often accompanied by sedation
Act by stimulating CTZ
Dr.Khalid Ghaznavi
(DPT)
13. Emetics –peripherally acting Mustard:
It is safe and easily available
Dose -1 tp in water Sodium chloride
Given orally
Causes reflex emesis
Dr.Khalid Ghaznavi
(DPT)
14. Emetics –both Ipecacuanha (Emetine):
Contains an alkaloid emetine.
Given as syrup (15-20ml) it produces vomiting in 15 min.
It is safe even in children.
Acts by irritating gastric mucosa as well as through CTZ
Dried root of ipecacuanha contains emetine
Takes 15 min or more for the effect
Used as syrup ipecac for inducing vomiting
15-20ml adults
10-15ml children
5ml infants
Dr.Khalid Ghaznavi
(DPT)
17. --Metoclopramide--
Introduced in early 1970s as a ‘gastric hurrying agent’
Widely used anti-emetic Actions
Act centrally by blocking dopamine D2 receptors on the CTZ
Increases the tone of lower esophageal sphincter
Enhance gastric peristalsis
Dr.Khalid Ghaznavi
(DPT)
18. Uses
In nausea and vomiting due to gastrointestinal disorders
Migraine
Post-operative period
Vomiting due to anti-cancer drugs and radiotherapy
Vomiting due to pregnancy
Dr.Khalid Ghaznavi
(DPT)
20. --Hyoscine--
Most effective for motion sickness/travelling sickness
Due to overstimulation of vestibular apparatus along
with psychological and environmental factors
Dr.Khalid Ghaznavi
(DPT)
21. 0.4 -0.6mg oral, I.M
Take 30 min before journey
Acts for 6 hours
Suitable for short brisk journeys
Dose should be repeated if journey is longer
Produces sedation and other anticholinergic side effects
Transdermal patch 1.5mg applied behind the ear
To be delivered over 3 days
Suppresses motion sickness
Have only mild side effects
Dr.Khalid Ghaznavi
(DPT)
22. --DICYCLOMINE--
10-20mg oral
Used for prophylaxis of motion sickness and for morning
sickness
It has been cleared of teratogenic potential
Dr.Khalid Ghaznavi
(DPT)
24. H1 Anti-Histamines
Some anti-histaminics are anti-emetic
They are useful mainly in motion sickness and
Lesser extent in morning sickness, post-operative and some other
forms of vomiting
Their antiemetic effect appears to be based on anti-cholinergic,
anti-histaminic and sedative properties
Also Used in pregnancy Dr.Khalid Ghaznavi
(DPT)
26. H1 antihistamines Cont..
All antimotion drugs are more effective when taken ½ -1
hr before commencing journey
Once sickness has started, it is more difficult to control
Dr.Khalid Ghaznavi
(DPT)
28. --Ondansetron--
5-hydroxytryptamine released in the gut is an important
transmitter of emesis
Ondansetron blocks 5-hydroxytryptamine 3 receptors in
GIT and CTZ and prevents vomiting
Dr.Khalid Ghaznavi
(DPT)
29. Ondansetron
Used in:
Postoperative period
Vomiting due to anti-cancer drugs and radiotherapy
Drug induced vomiting
Dr.Khalid Ghaznavi
(DPT)
31. --Neuroleptics--
Potent antiemetics
Act by blocking D2 receptors in the CTZ
Antiemetic dose is much lower than antipsychotic doses
These agents should not be administered until the cause of
vomiting has been diagnosed
Dr.Khalid Ghaznavi
(DPT)
32. Neuroleptics Cont…
Broad spectrum antiemetic , effective in;
Drug induced and post-anesthetic nausea and vomiting
Disease induced vomiting
Chemotherapy induced (mildly emetogenic)
Dr.Khalid Ghaznavi
(DPT)